Intensification of the Company’s international development with the appointment of a new CEO 

Read

Sensorion reports full year 2016 results in line with status of clinical development

Read

Sensorion receives European authorization to initiate Phase II clinical trial of SENS-111 to treat acute vertigo

Read

2017 Financial Calendar

Read

Sensorion Inner Ear Disease Product Candidates and Technology Subject of Multiple Presentations at ARO MidWinter Meeting 2017

Read

Next events